×
Claritev Total Liabilities 2019-2025 | CTEV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Claritev total liabilities from 2019 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
View More
Claritev Total Liabilities 2019-2025 | CTEV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Claritev total liabilities from 2019 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$46.1B
Hims & Hers Health (HIMS)
$11.6B
Doximity (DOCS)
$11.6B
Tempus AI (TEM)
$10B
IRhythm Technologies (IRTC)
$4.4B
Inspire Medical Systems (INSP)
$3.8B
Hinge Health (HNGE)
$3.7B
Privia Health (PRVA)
$2.5B
Enovis (ENOV)
$1.8B
Phreesia (PHR)
$1.6B
Schrodinger (SDGR)
$1.6B
10x Genomics (TXG)
$1.5B
Clover Health Investments (CLOV)
$1.5B
Azenta (AZTA)
$1.5B
Evolent Health (EVH)
$1.3B
Omnicell (OMCL)
$1.3B
Fulgent Genetics (FLGT)
$582M
Veradigm (MDRX)
$547M
Standard BioTools (LAB)
$475M
Butterfly Network (BFLY)
$450M
Talkspace (TALK)
$430M
Outset Medical (OM)
$333M
TruBridge (TBRG)
$329M
Health Catalyst (HCAT)
$269M
Nyxoah SA (NYXH)
$267M
SOPHiA GENETICS SA (SOPH)
$231M
CapsoVision (CV)
$203M
KORU Medical Systems (KRMD)
$149M
Zepp Health (ZEPP)
$139M
American Well (AMWL)
$126M